David Redfern Nn
Chief Strategy Officer
board
Glaxosmith
Philippines
Biography
David was appointed Chief Strategy Officer in May 2008 and is responsible for corporate development and strategic planning. In addition to his current role, he was appointed Chairman of the Board of ViiV Healthcare Ltd. in April 2011 and non-executive director of the Aspen Pharmacare Ltd. Board in February 2015. He is a member of the Corporate Executive Team
Research Interest
hepatology
